Catherine Ramsey
Stock Analyst at Baird
(3.66)
# 748
Out of 4,896 analysts
49
Total ratings
50%
Success rate
8.97%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Catherine Ramsey
Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
WAT Waters | Maintains: Outperform | $355 → $374 | $352.91 | +5.98% | 10 | May 7, 2025 | |
TWST Twist Bioscience | Maintains: Outperform | $54 → $44 | $38.03 | +15.70% | 7 | May 6, 2025 | |
RVTY Revvity | Maintains: Outperform | $127 → $125 | $101.50 | +23.15% | 5 | Apr 29, 2025 | |
ILMN Illumina | Maintains: Neutral | $127 → $90 | $99.25 | -9.32% | 5 | Mar 5, 2025 | |
NTRA Natera | Maintains: Outperform | $183 → $188 | $160.43 | +17.19% | 6 | Feb 28, 2025 | |
CSTL Castle Biosciences | Maintains: Outperform | $36 → $37 | $19.67 | +88.15% | 8 | Feb 28, 2025 | |
TMO Thermo Fisher Scientific | Maintains: Outperform | $695 → $665 | $434.86 | +52.92% | 2 | Nov 1, 2022 | |
A Agilent Technologies | Maintains: Outperform | $155 → $160 | $123.28 | +29.79% | 5 | Aug 17, 2022 | |
EXAS Exact Sciences | Maintains: Outperform | $90 → $75 | $51.91 | +44.48% | 1 | Aug 3, 2022 |
Waters
May 7, 2025
Maintains: Outperform
Price Target: $355 → $374
Current: $352.91
Upside: +5.98%
Twist Bioscience
May 6, 2025
Maintains: Outperform
Price Target: $54 → $44
Current: $38.03
Upside: +15.70%
Revvity
Apr 29, 2025
Maintains: Outperform
Price Target: $127 → $125
Current: $101.50
Upside: +23.15%
Illumina
Mar 5, 2025
Maintains: Neutral
Price Target: $127 → $90
Current: $99.25
Upside: -9.32%
Natera
Feb 28, 2025
Maintains: Outperform
Price Target: $183 → $188
Current: $160.43
Upside: +17.19%
Castle Biosciences
Feb 28, 2025
Maintains: Outperform
Price Target: $36 → $37
Current: $19.67
Upside: +88.15%
Thermo Fisher Scientific
Nov 1, 2022
Maintains: Outperform
Price Target: $695 → $665
Current: $434.86
Upside: +52.92%
Agilent Technologies
Aug 17, 2022
Maintains: Outperform
Price Target: $155 → $160
Current: $123.28
Upside: +29.79%
Exact Sciences
Aug 3, 2022
Maintains: Outperform
Price Target: $90 → $75
Current: $51.91
Upside: +44.48%